StockData
Eloxx Pharmaceuticals, Inc. logo

Eloxx Pharmaceuticals, Inc. (ELOX) stock

ELOXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$11.74−1.01 (-7.92%)

Close on Nov 17, 2026Market cap $79.70MP/E –Yield –

Eloxx Pharmaceuticals total assets

Total assets on the balance sheet at the end of each period.

Eloxx Pharmaceuticals's total assets was $63.39M at Jun 30, 2026. For fiscal 2025 it was $5.27M, up 77.1% from the year before. Over ten years it grew -16.8% a year on average. The highest annual figure on record is $58.95M in fiscal 2019.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$5.27M+77.1%
FY2024Dec 31, 2024$2.98M+73.8%
FY2023Dec 31, 2023$1.71M-91.9%
FY2022Dec 31, 2022$21.12M-53.2%
FY2021Dec 31, 2021$45.14M+70.5%
FY2020Dec 31, 2020$26.48M-55.1%
FY2019Dec 31, 2019$58.95M+16.2%
FY2018Dec 31, 2018$50.72M+449.7%
FY2016Jun 30, 2016$9.23M-52.8%
FY2015Jun 30, 2015$19.55M-41.4%
FY2014Jun 30, 2014$33.33M+369.7%
FY2013Jun 30, 2013$7.10M+2.1%
FY2012Jun 30, 2012$6.95M-19.1%
FY2011Jun 30, 2011$8.60M–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026$63.39M+3602.6%
Q1 FY2026CQ1 2026Mar 31, 2026$8.50M+40.7%
Q4 FY2025CQ4 2025Dec 31, 2025$5.27M-12.1%
Q4 FY2024CQ4 2024Dec 31, 2024$2.98M-58.7%
Q4 FY2023CQ4 2023Dec 31, 2023$1.71M-91.9%
Q3 FY2023CQ3 2023Sep 30, 2023$6.04M-77.5%
Q2 FY2023CQ2 2023Jun 30, 2023$5.99M-81.8%
Q1 FY2023CQ1 2023Mar 31, 2023$7.20M-83.5%
Q4 FY2022CQ4 2022Dec 31, 2022$21.12M-53.2%
Q3 FY2022CQ3 2022Sep 30, 2022$26.88M-51.5%
Q2 FY2022CQ2 2022Jun 30, 2022$32.94M-45.7%
Q1 FY2022CQ1 2022Mar 31, 2022$43.62M+114.2%
Q4 FY2021CQ4 2021Dec 31, 2021$45.14M+70.5%
Q3 FY2021CQ3 2021Sep 30, 2021$55.38M+68.1%
Q2 FY2021CQ2 2021Jun 30, 2021$60.61M+51.8%
Q1 FY2021CQ1 2021Mar 31, 2021$20.37M-56.7%
Q4 FY2020CQ4 2020Dec 31, 2020$26.48M-55.1%
Q3 FY2020CQ3 2020Sep 30, 2020$32.94M-51.6%
Q2 FY2020CQ2 2020Jun 30, 2020$39.92M-49.5%
Q1 FY2020CQ1 2020Mar 31, 2020$47.04M-17.3%
Q4 FY2019CQ4 2019Dec 31, 2019$58.95M+16.2%
Q3 FY2019CQ3 2019Sep 30, 2019$68.06M+20.4%
Q2 FY2019CQ2 2019Jun 30, 2019$79.04M+23.0%
Q1 FY2019CQ1 2019Mar 31, 2019$56.89M+197.0%
Q4 FY2018CQ4 2018Dec 31, 2018$50.72M+449.7%
Q3 FY2018CQ3 2018Sep 30, 2018$56.54M+435.4%
Q2 FY2018CQ2 2018Jun 30, 2018$64.27M+310.8%
Q1 FY2018CQ1 2018Mar 31, 2018$19.16M-1.5%
Q4 FY2016CQ2 2016Jun 30, 2016$9.23M-52.8%
Q3 FY2016CQ1 2016Mar 31, 2016$10.56M-37.6%
Q2 FY2016CQ4 2015Dec 31, 2015$15.64M-15.7%
Q1 FY2016CQ3 2015Sep 30, 2015$19.44M-30.9%
Q4 FY2015CQ2 2015Jun 30, 2015$19.55M-41.4%
Q3 FY2015CQ1 2015Mar 31, 2015$16.92M+54.4%
Q2 FY2015CQ4 2014Dec 31, 2014$18.55M–
Q1 FY2015CQ3 2014Sep 30, 2014$28.14M–
Q4 FY2014CQ2 2014Jun 30, 2014$33.33M–
Q3 FY2014CQ1 2014Mar 31, 2014$10.96M–

More Eloxx Pharmaceuticals figures

See a number that looks wrong?